What are the considerations for vaccine trial central lab testing?

Clinical Operations in Vaccine trials face increasingly complex and sample-intensive biospecimen operations.

They often deal with rapid and high-volume participant recruitment, across multiple sites scattered around the world. This makes the kitting, access to testing, sample management/logistics, and data management from enrollment to database lock demanding.

Vaccine sponsors partner with LabConnect to access a central lab model specialized in vaccine studies:

• >96 Global Infectious Disease & Vaccine Studies

• <2% Query Rate and Early Database Lock (DBL)

• Pre-built Custom Kits and Rapid Re-supply

• Access to Sample Processing and Central/Specialty Testing in 30 countries (incl. South America, Africa, and APAC)

• Real-time Sample Tracking for a Traceable Chain-of-Custody (CoC)